BioSpace News Archive

Akeso, Inc. announced that the CDE of China’s National Medical Products Administration has approved the IND application for the initiation of the open-label, multicenter phase II trial in China using Cadonilimab in combination with Docetaxel in patients with advanced NSCLC which progressed on combination therapy of PD-1/L1 inhibitor and platinum-based doublet chemotherapy.

Government authorities and hospital organizations have been taking necessary steps to spread information about medical services, provide a smooth experience, and establish their countries as medical hubs.

Any kind of surgeries involve a variety of different components and apparatus. One of the most common medical device used by doctors and surgeons is the surgical sutures. Sutures help to hold the wounded body tissues together.

GlycoPath has received an STTR grant from the National Cancer Institute to utilize their patent-pending GlycoTyper™ technology for the development of a biomarker panel for hepatocellular carcinoma, a major cancer in the USA and rest of the world.

Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that Anthony H. Kim, Chief Financial Officer of Marker Therapeutics, will present at two upcoming investor conferences in March.

Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report fourth quarter 2021 financial results and pipeline updates on Tuesday, March 15, 2022, after U.S. financial markets close.

Amgen announced the groundbreaking of its newest biomanufacturing facility, located in Holly Springs, North Carolina.

Flamingo Therapeutics., a biotechnology company pioneering RNA-targeting therapies in oncology, announced that Mike Garrett, Chief Executive Officer, will present at the BioCapital Europe 2022 meeting on March 10th, 2022 at 5pm CET/11am ET.

Nevro Corp. announced that Noridian, the Medicare Administrative Contractor that oversees the majority of the western United States, released an update to their Local Coverage Billing and Coding article for spinal cord stimulators for chronic pain to include two new ICD-10 codes that cover Painful Diabetic Neuropathy.

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022 at 10:00am Eastern Time.